{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:08:03Z","timestamp":1777856883597,"version":"3.51.4"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12640-026-00790-6","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T02:12:16Z","timestamp":1774577536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Decoding the RNA Shield: HNRNPC and YTHDF2 Act as Guardians of Neurons in Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"44","author":[{"family":"Shreya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2450-2975","authenticated-orcid":false,"given":"Khadga Raj","family":"Aran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"issue":"7","key":"790_CR66","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1021\/acs.chemrestox.5b00528","volume":"29","author":"DG Anderson","year":"2016","unstructured":"Anderson DG, Florang VR, Schamp JH, Buettner GR, Doorn JA (2016) Antioxidant-mediated modulation of protein reactivity for 3, 4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite. Chem Res Toxicol 29(7):1098\u20131107. https:\/\/doi.org\/10.1021\/acs.chemrestox.5b00528","journal-title":"Chem Res Toxicol"},{"key":"790_CR43","doi-asserted-by":"publisher","unstructured":"Barbosa, A. F., Voos, M. C., Chen, J., Francato, D. C. V., Souza, C. D. O., Barbosa,E. R., \u2026 Mansur, L. L. (2017). Cognitive or cognitive-motor executive function tasks? Evaluating verbal fluency measures in people with parkinson\u2019s disease. BioMed Research International 2017(1):7893975. https:\/\/doi.org\/10.1155\/2017\/7893975","DOI":"10.1155\/2017\/7893975"},{"issue":"6\u20137","key":"790_CR27","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.bbabio.2010.02.030","volume":"1797","author":"G Benard","year":"2010","unstructured":"Benard G, Bellance N, Jose C, Melser S, Nouette-Gaulain K, Rossignol R (2010) Multi-site control and regulation of mitochondrial energy production. Biochim et Biophys Acta (BBA)-Bioenergetics 1797(6\u20137):698\u2013709. https:\/\/doi.org\/10.1016\/j.bbabio.2010.02.030","journal-title":"Biochim et Biophys Acta (BBA)-Bioenergetics"},{"issue":"3","key":"790_CR31","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s12276-020-0407-z","volume":"52","author":"SH Boo","year":"2020","unstructured":"Boo SH, Kim YK (2020) The emerging role of RNA modifications in the regulation of mRNA stability. Exp Mol Med 52(3):400\u2013408. https:\/\/doi.org\/10.1038\/s12276-020-0407-z","journal-title":"Exp Mol Med"},{"issue":"3","key":"790_CR90","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/ncrna6030040","volume":"6","author":"P Briata","year":"2020","unstructured":"Briata P, Gherzi R (2020) Long non-coding RNA-ribonucleoprotein networks in the post-transcriptional control of gene expression. Non-coding RNA 6(3):40. https:\/\/doi.org\/10.3390\/ncrna6030040","journal-title":"Non-coding RNA"},{"issue":"19","key":"790_CR69","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1093\/bioinfomatics\/btq431","volume":"26","author":"BS Carvalho","year":"2010","unstructured":"Carvalho BS, Irizarry RA (2010) A framework for oligonucleotide microarray preprocessing. Bioinformatics 26(19):2363\u20132367. https:\/\/doi.org\/10.1093\/bioinfomatics\/btq431","journal-title":"Bioinformatics"},{"issue":"21","key":"790_CR22","doi-asserted-by":"publisher","first-page":"11870","DOI":"10.3390\/ijms222111870","volume":"22","author":"B Chatterjee","year":"2021","unstructured":"Chatterjee B, Shen CK, Majumder P (2021) RNA modifications and RNA metabolism in neurological disease pathogenesis. Int J Mol Sci 22(21):11870. https:\/\/doi.org\/10.3390\/ijms222111870","journal-title":"Int J Mol Sci"},{"key":"790_CR83","doi-asserted-by":"publisher","first-page":"1162607","DOI":"10.3389\/fimmu.2023.1162607","volume":"14","author":"L Chen","year":"2023","unstructured":"Chen L, Gao Y, Xu S, Yuan J, Wang M, Li T, Gong J (2023) N6-methyladenosine reader YTHDF family in biological processes: structures, roles, and mechanisms. Front Immunol 14:1162607. https:\/\/doi.org\/10.3389\/fimmu.2023.1162607","journal-title":"Front Immunol"},{"issue":"11","key":"790_CR84","doi-asserted-by":"publisher","first-page":"2003902","DOI":"10.1002\/advs.202003902","volume":"8","author":"X Chen","year":"2021","unstructured":"Chen X, Zhao Q, Zhao YL, Chai GS, Cheng W, Zhao Z, Cao N (2021) Targeted RNA N6-methyladenosine demethylation controls cell fate transition in human pluripotent stem cells. Adv Sci 8(11):2003902. https:\/\/doi.org\/10.1002\/advs.202003902","journal-title":"Adv Sci"},{"issue":"7","key":"790_CR16","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1093\/nar\/gkp1229","volume":"38","author":"SJ Cho","year":"2010","unstructured":"Cho SJ, Zhang J, Chen X (2010) RNPC1 modulates the RNA-binding activity of, and cooperates with, HuR to regulate p21 mRNA stability. Nucleic Acids Res 38(7):2256\u20132267. https:\/\/doi.org\/10.1093\/nar\/gkp1229","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"790_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Elbaz A, Nichols E, Abbasi N, Abd-Allah F, Abdelalim A, Adsuar JC, Ansha MG, Brayne C, Choi JY, Collado-Mateo D (2018) Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17(11):939\u2013953. https:\/\/doi.org\/10.1016\/S1474-4422(18)30295-3","journal-title":"Lancet Neurol"},{"issue":"1","key":"790_CR33","doi-asserted-by":"publisher","first-page":"12626","DOI":"10.1038\/ncomms12626","volume":"7","author":"H Du","year":"2016","unstructured":"Du H, Zhao Y, He J, Zhang Y, Xi H, Liu M, Wu L (2016) YTHDF2 destabilizes m6A-containing RNA through direct recruitment of the CCR4\u2013NOT deadenylase complex. Nat Commun 7(1):12626. https:\/\/doi.org\/10.1038\/ncomms12626","journal-title":"Nat Commun"},{"issue":"21","key":"790_CR52","doi-asserted-by":"publisher","first-page":"11337","DOI":"10.3390\/ijms252111337","volume":"25","author":"Y Fang","year":"2024","unstructured":"Fang Y, Liu X, Liu Y, Xu N (2024) Insights into the mode and mechanism of interactions between RNA and RNA-binding proteins. Int J Mol Sci 25(21):11337. https:\/\/doi.org\/10.3390\/ijms252111337","journal-title":"Int J Mol Sci"},{"issue":"1","key":"790_CR88","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13045-024-01546-5","volume":"17","author":"G Feng","year":"2024","unstructured":"Feng G, Wu Y, Hu Y, Shuai W, Yang X, Li Y, Wang G (2024) Small molecule inhibitors targeting m6A regulators. J Hematol Oncol 17(1):30. https:\/\/doi.org\/10.1186\/s13045-024-01546-5","journal-title":"J Hematol Oncol"},{"issue":"4","key":"790_CR95","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3233\/JPD-230457","volume":"14","author":"JT Gionco","year":"2024","unstructured":"Gionco JT, Bernstein AI (2024) Emerging role of environmental epitranscriptomics and RNA modifications in Parkinson\u2019s disease. J Parkinson\u2019s disease 14(4):643\u2013656. https:\/\/doi.org\/10.3233\/JPD-230457","journal-title":"J Parkinson\u2019s disease"},{"issue":"11","key":"790_CR65","doi-asserted-by":"publisher","first-page":"5999","DOI":"10.3390\/ijms22115999","volume":"22","author":"DS Goldstein","year":"2021","unstructured":"Goldstein DS (2021) The catecholaldehyde hypothesis for the pathogenesis of catecholaminergic neurodegeneration: what we know and what we do not know. Int J Mol Sci 22(11):5999. https:\/\/doi.org\/10.3390\/ijms22115999","journal-title":"Int J Mol Sci"},{"issue":"4","key":"790_CR59","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.3892\/ijmm.2018.3406","volume":"41","author":"JD Guo","year":"2018","unstructured":"Guo JD, Zhao X, Li Y, Li GR, Liu XL (2018) Damage to dopaminergic neurons by oxidative stress in Parkinson\u2019s disease. Int J Mol Med 41(4):1817\u20131825. https:\/\/doi.org\/10.3892\/ijmm.2018.3406","journal-title":"Int J Mol Med"},{"issue":"6","key":"790_CR23","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/cge.13524","volume":"95","author":"S Harmsen","year":"2019","unstructured":"Harmsen S, Buchert R, Mayatepek E, Haack TB, Distelmaier F (2019) Bain type of X-linked syndromic mental retardation in boys. Clin Genet 95(6):734\u2013735. https:\/\/doi.org\/10.1111\/cge.13524","journal-title":"Clin Genet"},{"issue":"4","key":"790_CR47","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/ibra.12183","volume":"10","author":"MATS Hashmi","year":"2024","unstructured":"Hashmi MATS, Fatima H, Ahmad S, Rehman A, Safdar F (2024) The interplay between epitranscriptomic RNA modifications and neurodegenerative disorders: Mechanistic insights and potential therapeutic strategies. ibrain 10(4):395\u2013426. https:\/\/doi.org\/10.1002\/ibra.12183","journal-title":"ibrain"},{"issue":"3","key":"790_CR57","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/jnc.15882","volume":"166","author":"H He","year":"2023","unstructured":"He H, Zhang Q, Liao J, Lei J, Luo M, Huang J, Xiao Y (2023) METTL14 is decreased and regulates m6A modification of \u03b1-synuclein in Parkinson\u2019s disease. J Neurochem 166(3):609\u2013622. https:\/\/doi.org\/10.1111\/jnc.15882","journal-title":"J Neurochem"},{"issue":"1","key":"790_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1006\/exnr.2000.7483","volume":"166","author":"DW Howells","year":"2000","unstructured":"Howells DW, Porritt M, Wong JYF, Batchelor PE, Kalnins R, Hughes AJ, Donnan GA (2000) Reduced BDNF mRNA expression in the Parkinson\u2019s disease substantia nigra. Exp Neurol 166(1):127\u2013135. https:\/\/doi.org\/10.1006\/exnr.2000.7483","journal-title":"Exp Neurol"},{"key":"790_CR24","doi-asserted-by":"publisher","first-page":"578265","DOI":"10.1016\/j.jneuroim.2023.278265","volume":"387","author":"R Huang","year":"2024","unstructured":"Huang R, Sun M, Wang W, Yu X, Liu F (2024) YTHDF2 alleviates microglia activation via promoting circHIPK2 degradation. J Neuroimmunol 387:578265. https:\/\/doi.org\/10.1016\/j.jneuroim.2023.278265","journal-title":"J Neuroimmunol"},{"key":"790_CR94","doi-asserted-by":"publisher","DOI":"10.2174\/0115665232357160250123113148","author":"SA Jan","year":"2025","unstructured":"Jan SA, Debnath A, Singh RK, Tyagi PK, Singh S, Singh AK (2025) Targeting Undruggable Proteins: The siRNA Revolution Beyond Small Molecules-Advances, Challenges, and Future Prospects in Therapeutic Innovation. Curr Gene Ther. https:\/\/doi.org\/10.2174\/0115665232357160250123113148","journal-title":"Curr Gene Ther"},{"key":"790_CR72","doi-asserted-by":"publisher","first-page":"962774","DOI":"10.3389\/fgene.2022.962774","volume":"13","author":"L Jiang","year":"2022","unstructured":"Jiang L, Li X, Wang S, Yuan Z, Cheng J (2022) The role and regulatory mechanism of m6A methylation in the nervous system. Front Genet 13:962774. https:\/\/doi.org\/10.3389\/fgene.2022.962774","journal-title":"Front Genet"},{"issue":"5","key":"790_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3390\/cells13050457","volume":"13","author":"A Kobayashi","year":"2024","unstructured":"Kobayashi A, Kitagawa Y, Nasser A, Wakimoto H, Yamada K, Tanaka S (2024) Emerging roles and mechanisms of RNA modifications in neurodegenerative diseases and glioma. Cells 13(5):457. https:\/\/doi.org\/10.3390\/cells13050457","journal-title":"Cells"},{"issue":"19","key":"790_CR82","doi-asserted-by":"publisher","first-page":"7113","DOI":"10.3390\/ijms21197113","volume":"21","author":"G Kouroupi","year":"2020","unstructured":"Kouroupi G, Antoniou N, Prodromidou K, Taoufik E, Matsas R (2020) Patient-derived induced pluripotent stem cell-based models in Parkinson\u2019s disease for drug identification. Int J Mol Sci 21(19):7113. https:\/\/doi.org\/10.3390\/ijms21197113","journal-title":"Int J Mol Sci"},{"issue":"3","key":"790_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.tig.2019.12.007","volume":"36","author":"Y Lee","year":"2020","unstructured":"Lee Y, Choe J, Park OH, Kim YK (2020) Molecular mechanisms driving mRNA degradation by m6A modification. Trends Genet 36(3):177\u2013188. https:\/\/doi.org\/10.1016\/j.tig.2019.12.007","journal-title":"Trends Genet"},{"issue":"1","key":"790_CR7","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/s41467-025-56173-6","volume":"16","author":"C Liu","year":"2025","unstructured":"Liu C, Liang H, Wan AH, Xiao M, Sun L, Yu Y, Wan G (2025) Decoding the m6a epitranscriptomic landscape for biotechnological applications using a direct rna sequencing approach. Nat Commun 16(1):798. https:\/\/doi.org\/10.1038\/s41467-025-56173-6","journal-title":"Nat Commun"},{"issue":"7540","key":"790_CR14","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nature14234","volume":"518","author":"N Liu","year":"2015","unstructured":"Liu N, Dai Q, Zheng G, He C, Parisien M, Pan T (2015) N 6-methyladenosine-dependent RNA structural switches regulate RNA\u2013protein interactions. Nature 518(7540):560\u2013564. https:\/\/doi.org\/10.1038\/nature14234","journal-title":"Nature"},{"key":"790_CR100","doi-asserted-by":"publisher","unstructured":"Liu Q, Yang F, Wu S, Yuan K, Huang L, Cai S (2024a) Ferroptosis, M6A and immune checkpoint-related gene expression in the middle temporal gyrus of the Alzheimer's disease brain. Meta-Radiol 2(1):100048. https:\/\/doi.org\/10.1016\/j.metrad.2024.100048","DOI":"10.1016\/j.metrad.2024.100048"},{"issue":"1","key":"790_CR80","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-024-01777-5","volume":"9","author":"WW Liu","year":"2024","unstructured":"Liu WW, Zheng SQ, Li T, Fei YF, Wang C, Zhang S, Wang H (2024b) RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy. Signal Transduct Target Ther 9(1):70. https:\/\/doi.org\/10.1038\/s41392-024-01777-5","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"790_CR93","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s44318-024-00352-6","volume":"44","author":"Y Li","year":"2025","unstructured":"Li Y, Sun S (2025) RNA dysregulation in neurodegenerative diseases. EMBO J 44(3):613\u2013638. https:\/\/doi.org\/10.1038\/s44318-024-00352-6","journal-title":"EMBO J"},{"issue":"10","key":"790_CR15","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.3390\/biom13101434","volume":"13","author":"Z Li","year":"2023","unstructured":"Li Z, Wei H, Hu D, Li X, Guo Y, Ding X, Zhang L (2023) Research progress on the structural and functional roles of hnRNPs in muscle development. Biomolecules 13(10):1434. https:\/\/doi.org\/10.3390\/biom13101434","journal-title":"Biomolecules"},{"key":"790_CR11","doi-asserted-by":"publisher","first-page":"114583","DOI":"10.1016\/j.biopha.2023.114583","volume":"162","author":"J Lv","year":"2023","unstructured":"Lv J, Xing L, Zhong X, Li K, Liu M, Du K (2023) Role of N6-methyladenosine modification in central nervous system diseases and related therapeutic agents. Biomed Pharmacother 162:114583. https:\/\/doi.org\/10.1016\/j.biopha.2023.114583","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"790_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13578-025-01386-x","volume":"15","author":"X Ma","year":"2025","unstructured":"Ma X, Li H, Zhao Z, Li C, Wang M, Zhang L, Hua J (2025) The HNRNPC\/CELF2 signaling pathway drives glycolytic reprogramming and mitochondrial dysfunction in drug-resistant acute myeloid leukemia. Cell Bioscience 15(1):61. https:\/\/doi.org\/10.1186\/s13578-025-01386-x","journal-title":"Cell Bioscience"},{"key":"790_CR97","doi-asserted-by":"publisher","unstructured":"Miller, C., Ealy, A., Gregory, A., Janarthanam, C., Albers, W., Richardson, G., \u2026Kanthasamy, A. G. (2025). Pathological \u03b1-synuclein dysregulates epitranscriptomic writer METTL3 to drive neuroinflammation in microglia. Cell reports 44(5). https:\/\/doi.org\/10.1016\/j.celrep.2025.115618","DOI":"10.1016\/j.celrep.2025.115618"},{"issue":"1","key":"790_CR91","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1089\/nat.2015.0566","volume":"26","author":"E Mondrag\u00f3n","year":"2016","unstructured":"Mondrag\u00f3n E, Maher III, L. J (2016) Anti-transcription factor RNA aptamers as potential therapeutics. nucleic acid Ther 26(1):29\u201343. https:\/\/doi.org\/10.1089\/nat.2015.0566","journal-title":"nucleic acid Ther"},{"issue":"12","key":"790_CR6","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/j.molcel.2022.05.029","volume":"82","author":"S Murakami","year":"2022","unstructured":"Murakami S, Jaffrey SR (2022) Hidden codes in mRNA: control of gene expression by m6A. Mol Cell 82(12):2236\u20132251. https:\/\/doi.org\/10.1016\/j.molcel.2022.05.029","journal-title":"Mol Cell"},{"key":"790_CR51","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.semcdb.2017.08.053","volume":"75","author":"S Nasif","year":"2018","unstructured":"Nasif S, Contu L, M\u00fchlemann O (2018) Beyond quality control: The role of nonsense-mediated mRNA decay (NMD) in regulating gene expression. InSeminars cell Dev biology (Vol 75:78\u201387. https:\/\/doi.org\/10.1016\/j.semcdb.2017.08.053. Academic Press","journal-title":"InSeminars cell Dev biology (Vol"},{"issue":"7","key":"790_CR37","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1080\/15476286.2017.1306171","volume":"14","author":"J Neve","year":"2017","unstructured":"Neve J, Patel R, Wang Z, Louey A, Furger AM (2017) Cleavage and polyadenylation: ending the message expands gene regulation. RNA Biol 14(7):865\u2013890. https:\/\/doi.org\/10.1080\/15476286.2017.1306171","journal-title":"RNA Biol"},{"key":"790_CR60","doi-asserted-by":"publisher","first-page":"826193","DOI":"10.3389\/fncel.2022.826193","volume":"16","author":"A Ni","year":"2022","unstructured":"Ni A, Ernst C (2022) Evidence that substantia nigra pars compacta dopaminergic neurons are selectively vulnerable to oxidative stress because they are highly metabolically active. Front Cell Neurosci 16:826193. https:\/\/doi.org\/10.3389\/fncel.2022.826193","journal-title":"Front Cell Neurosci"},{"issue":"8","key":"790_CR34","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.ajhg.2023.07.005","volume":"110","author":"E Niggl","year":"2023","unstructured":"Niggl E, Bouman A, Briere LC, Hoogenboezem RM, Wallaard I, Park J, Crouse AB (2023) HNRNPC haploinsufficiency affects alternative splicing of intellectual disability-associated genes and causes a neurodevelopmental disorder. Am J Hum Genet 110(8):1414\u20131435. https:\/\/doi.org\/10.1016\/j.ajhg.2023.07.005","journal-title":"Am J Hum Genet"},{"issue":"1","key":"790_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Lang AE (2017) Parkinson disease. Nat reviews Disease primers 3(1):1\u201321. https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Nat reviews Disease primers"},{"issue":"12","key":"790_CR12","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"issue":"9","key":"790_CR49","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.3390\/ijms23094653","volume":"23","author":"VE Provasek","year":"2022","unstructured":"Provasek VE, Mitra J, Malojirao VH, Hegde ML (2022) DNA double-strand breaks as pathogenic lesions in neurological disorders. Int J Mol Sci 23(9):4653. https:\/\/doi.org\/10.3390\/ijms23094653","journal-title":"Int J Mol Sci"},{"issue":"3","key":"790_CR36","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00018-018-2940-7","volume":"76","author":"M Pu","year":"2019","unstructured":"Pu M, Chen J, Tao Z, Miao L, Qi X, Wang Y, Ren J (2019) Regulatory network of miRNA on its target: coordination between transcriptional and post-transcriptional regulation of gene expression. Cell Mol Life Sci 76(3):441\u2013451. https:\/\/doi.org\/10.1007\/s00018-018-2940-7","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"790_CR41","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/jamaneurol.2016.2742","volume":"73","author":"XY Qin","year":"2016","unstructured":"Qin XY, Zhang SP, Cao C, Loh YP, Cheng Y (2016) Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: a systematic review and meta-analysis. JAMA Neurol 73(11):1316\u20131324. https:\/\/doi.org\/10.1001\/jamaneurol.2016.2742","journal-title":"JAMA Neurol"},{"key":"790_CR63","doi-asserted-by":"publisher","first-page":"9919129","DOI":"10.1155\/2021\/9919129","volume":"20211","author":"W Quan","year":"2021","unstructured":"Quan W, Li J, Liu L, Zhang Q, Qin Y, Pei X, Chen J (2021) Influence of N6-Methyladenosine Modification Gene HNRNPC on Cell Phenotype in Parkinson\u2019s Disease. Parkinson\u2019s disease 20211:9919129. https:\/\/doi.org\/10.1155\/2021\/9919129","journal-title":"Parkinson\u2019s disease"},{"issue":"2","key":"790_CR92","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3390\/molecules27020536","volume":"27","author":"AM Quemener","year":"2022","unstructured":"Quemener AM, Centomo ML, Sax SL, Panella R (2022) Small drugs, huge impact: the extraordinary impact of antisense oligonucleotides in research and drug development. Molecules 27(2):536. https:\/\/doi.org\/10.3390\/molecules27020536","journal-title":"Molecules"},{"issue":"8","key":"790_CR53","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.3390\/ijms19082280","volume":"19","author":"S Ravanidis","year":"2018","unstructured":"Ravanidis S, Kattan FG, Doxakis E (2018) Unraveling the pathways to neuronal homeostasis and disease: mechanistic insights into the role of RNA-binding proteins and associated factors. Int J Mol Sci 19(8):2280. https:\/\/doi.org\/10.3390\/ijms19082280","journal-title":"Int J Mol Sci"},{"issue":"11","key":"790_CR1","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/S1474-4422(18)30355-7","volume":"17","author":"WA Rocca","year":"2018","unstructured":"Rocca WA (2018) The burden of Parkinson\u2019s disease: a worldwide perspective. Lancet Neurol 17(11):928\u2013929. https:\/\/doi.org\/10.1016\/S1474-4422(18)30355-7","journal-title":"Lancet Neurol"},{"issue":"7","key":"790_CR77","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.3390\/cells9071717","volume":"9","author":"JA Rodr\u00edguez-G\u00f3mez","year":"2020","unstructured":"Rodr\u00edguez-G\u00f3mez JA, Kavanagh E, Engskog-Vlachos P, Engskog MK, Herrera AJ, Espinosa-Oliva AM, Burguillos MA (2020) Microglia: agents of the CNS pro-inflammatory response. Cells 9(7):1717. https:\/\/doi.org\/10.3390\/cells9071717","journal-title":"Cells"},{"key":"790_CR61","doi-asserted-by":"publisher","unstructured":"Santana-Rom\u00e1n E, Soto-Rojas LO, Manjarrez E, Arias-Carri\u00f3n O (2025) Nigrostriatal dopaminergic vulnerability in Parkinson\u2019s disease: Neuroprotective strategies. Neural Regeneration Res 10\u20134103. https:\/\/doi.org\/10.4103\/NRR.NRR-D-25-00380","DOI":"10.4103\/NRR.NRR-D-25-00380"},{"issue":"1","key":"790_CR67","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3390\/ijms25010360","volume":"25","author":"K Saramowicz","year":"2023","unstructured":"Saramowicz K, Siwecka N, Galita G, Kucharska-Lusina A, Rozp\u0119dek-Kami\u0144ska W, Majsterek I (2023) Alpha-synuclein contribution to neuronal and glial damage in Parkinson\u2019s disease. Int J Mol Sci 25(1):360. https:\/\/doi.org\/10.3390\/ijms25010360","journal-title":"Int J Mol Sci"},{"issue":"7","key":"790_CR81","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nrg.2016.46","volume":"17","author":"CR Sibley","year":"2016","unstructured":"Sibley CR, Blazquez L, Ule J (2016) Lessons from non-canonical splicing. Nat Rev Genet 17(7):407\u2013421. https:\/\/doi.org\/10.1038\/nrg.2016.46","journal-title":"Nat Rev Genet"},{"key":"790_CR70","doi-asserted-by":"publisher","first-page":"656849","DOI":"10.3389\/fcell.2021.656849","volume":"9","author":"G Sokpor","year":"2021","unstructured":"Sokpor G, Xie Y, Nguyen HP, Tuoc T (2021) Emerging role of m6 A methylome in brain development: implications for neurological disorders and potential treatment. Front Cell Dev Biology 9:656849. https:\/\/doi.org\/10.3389\/fcell.2021.656849","journal-title":"Front Cell Dev Biology"},{"key":"790_CR18","doi-asserted-by":"publisher","first-page":"116576","DOI":"10.1016\/j.bcp.2024.116576","volume":"230","author":"L Song","year":"2024","unstructured":"Song L, Liu H, Yang W, Yin H, Wang J, Guo M, Yang Z (2024) Biological functions of the m6A reader YTHDF2 and its role in central nervous system disorders. Biochem Pharmacol 230:116576. https:\/\/doi.org\/10.1016\/j.bcp.2024.116576","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"790_CR45","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1093\/nar\/gks144","volume":"40","author":"JE Squires","year":"2012","unstructured":"Squires JE, Patel HR, Nousch M, Sibbritt T, Humphreys DT, Parker BJ, Preiss T (2012) Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA. Nucleic Acids Res 40(11):5023\u20135033. https:\/\/doi.org\/10.1093\/nar\/gks144","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"790_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/0972-2327.167713","volume":"19","author":"P Surathi","year":"2016","unstructured":"Surathi P, Jhunjhunwala K, Yadav R, Pal PK (2016) Research in Parkinson\u2019s disease in India: A review. Ann Indian Acad Neurol 19(1):9\u201320. https:\/\/doi.org\/10.4103\/0972-2327.167713","journal-title":"Ann Indian Acad Neurol"},{"issue":"22","key":"790_CR86","doi-asserted-by":"publisher","first-page":"12284","DOI":"10.3390\/ijms252212284","volume":"25","author":"H Tani","year":"2024","unstructured":"Tani H (2024) Recent advances and prospects in RNA drug development. Int J Mol Sci 25(22):12284. https:\/\/doi.org\/10.3390\/ijms252212284","journal-title":"Int J Mol Sci"},{"issue":"1","key":"790_CR79","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41392-024-01734-2","volume":"9","author":"Y Tao","year":"2024","unstructured":"Tao Y, Zhang Q, Wang H, Yang X, Mu H (2024) Alternative splicing and related RNA binding proteins in human health and disease. Signal Transduct Target Therapy 9(1):26. https:\/\/doi.org\/10.1038\/s41392-024-01734-2","journal-title":"Signal Transduct Target Therapy"},{"issue":"11","key":"790_CR89","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.2174\/092986707780597961","volume":"14","author":"S Thameem Dheen","year":"2007","unstructured":"Thameem Dheen S, Kaur C, Ling EA (2007) Microglial activation and its implications in the brain diseases. Curr Med Chem 14(11):1189\u20131197. https:\/\/doi.org\/10.2174\/092986707780597961","journal-title":"Curr Med Chem"},{"issue":"4","key":"790_CR55","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s00018-022-04240-2","volume":"79","author":"GK Tofaris","year":"2022","unstructured":"Tofaris GK (2022) Initiation and progression of \u03b1-synuclein pathology in Parkinson\u2019s disease. Cell Mol Life Sci 79(4):210. https:\/\/doi.org\/10.1007\/s00018-022-04240-2","journal-title":"Cell Mol Life Sci"},{"key":"790_CR40","doi-asserted-by":"publisher","first-page":"104982","DOI":"10.1016\/j.neuint.2021.104982","volume":"144","author":"JJ Trivi\u00f1o","year":"2021","unstructured":"Trivi\u00f1o JJ, von Bernhardi R (2021) The effect of aged microglia on synaptic impairment and its relevance in neurodegenerative diseases. Neurochem Int 144:104982. https:\/\/doi.org\/10.1016\/j.neuint.2021.104982","journal-title":"Neurochem Int"},{"issue":"1","key":"790_CR25","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41392-023-01638-7","volume":"8","author":"C Wang","year":"2023","unstructured":"Wang C, Hou X, Guan Q, Zhou H, Zhou L, Liu L, Liu H (2023) RNA modification in cardiovascular disease: implications for therapeutic interventions. Signal Transduct Target Ther 8(1):412. https:\/\/doi.org\/10.1038\/s41392-023-01638-7","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"790_CR54","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40659-025-00585-7","volume":"58","author":"J Wang","year":"2025","unstructured":"Wang J, Liu M, Zhao J, Hu P, Gao L, Tian S, Zhang J, Liu H, Xu X, He Z (2025) Oxidative stress and dysregulated long noncoding RNAs in the pathogenesis of Parkinson\u2019s disease. Biol Res 58(1):7. https:\/\/doi.org\/10.1186\/s40659-025-00585-7","journal-title":"Biol Res"},{"issue":"3","key":"790_CR71","doi-asserted-by":"publisher","first-page":"887","DOI":"10.4103\/NRR.NRR-D-23-01592","volume":"20","author":"J Wang","year":"2025","unstructured":"Wang J, Ran Y, Li Z, Zhao T, Zhang F, Wang J, Chen X (2025) Salsolinol as an RNA m6A methylation inducer mediates dopaminergic neuronal death by regulating YAP1 and autophagy. Neural Regen Res 20(3):887\u2013899. https:\/\/doi.org\/10.4103\/NRR.NRR-D-23-01592","journal-title":"Neural Regen Res"},{"key":"790_CR17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/978-3-030-71612-7_13","volume-title":"Epitranscriptomics","author":"L Wang","year":"2021","unstructured":"Wang L, Maimaitiyiming Y, Su K, Hsu CH (2021) RNA modification: the mediator between cellular stresses and biological effects. Epitranscriptomics. Springer International Publishing, Cham, pp 353\u2013390. https:\/\/doi.org\/10.1007\/978-3-030-71612-7_13"},{"issue":"1","key":"790_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu Y, Zhou J (2015) Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Translational neurodegeneration 4(1):19. https:\/\/doi.org\/10.1186\/s40035-015-0042-0","journal-title":"Translational neurodegeneration"},{"issue":"5","key":"790_CR26","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3390\/biom15050617","volume":"15","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zhao T, Yuan C, Chen X (2025) The Role of N 6-Methyladenosine (m6A) RNA Modification in the Pathogenesis of Parkinson\u2019s Disease. Biomolecules 15(5):617. https:\/\/doi.org\/10.3390\/biom15050617","journal-title":"Biomolecules"},{"issue":"2","key":"790_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/jnc.14481","volume":"147","author":"J Widagdo","year":"2018","unstructured":"Widagdo J, Anggono V (2018) The m6A-epitranscriptomic signature in neurobiology: from neurodevelopment to brain plasticity. J Neurochem 147(2):137\u2013152. https:\/\/doi.org\/10.1111\/jnc.14481","journal-title":"J Neurochem"},{"issue":"1","key":"790_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12929-020-00636-z","volume":"27","author":"YY Wu","year":"2020","unstructured":"Wu YY, Kuo HC (2020) Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases. J Biomed Sci 27(1):49. https:\/\/doi.org\/10.1186\/s12929-020-00636-z","journal-title":"J Biomed Sci"},{"issue":"1","key":"790_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/15476286.2021.2015175","volume":"19","author":"S Xing","year":"2022","unstructured":"Xing S, Wang J, Wu R, Hefti MM, Crary JF, Lu Y (2022) Identification of HnRNPC as a novel Tau exon 10 splicing factor using RNA antisense purification mass spectrometry. RNA Biol 19(1):104\u2013116. https:\/\/doi.org\/10.1080\/15476286.2021.2015175","journal-title":"RNA Biol"},{"key":"790_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/bs.irn.2019.06.003","volume":"147","author":"X Xu","year":"2019","unstructured":"Xu X, Fu Z, Le W (2019) Exercise and Parkinson\u2019s disease. Int Rev Neurobiol 147:45\u201374. https:\/\/doi.org\/10.1016\/bs.irn.2019.06.003","journal-title":"Int Rev Neurobiol"},{"issue":"1","key":"790_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/ijms17010003","volume":"17","author":"M Yabas","year":"2015","unstructured":"Yabas M, Elliott H, Hoyne GF (2015) The role of alternative splicing in the control of immune homeostasis and cellular differentiation. Int J Mol Sci 17(1):3. https:\/\/doi.org\/10.3390\/ijms17010003","journal-title":"Int J Mol Sci"},{"key":"790_CR10","doi-asserted-by":"publisher","unstructured":"Yang J, Xu B, Cui L, Lang Y (2021) Identification and development of the N6-methyladenosine RNA signature and immune microenvironment estimation in Parkinson\u2019s disease. Front Genet 12:650803. https:\/\/doi.org\/10.3389\/fgene.2021.650803","DOI":"10.3389\/fgene.2021.650803"},{"issue":"1","key":"790_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11434-014-0695-6","volume":"60","author":"Y Yang","year":"2015","unstructured":"Yang Y, Sun BF, Xiao W, Yang X, Sun HY, Zhao YL, Yang YG (2015) Dynamic m6A modification and its emerging regulatory role in mRNA splicing. Sci Bull 60(1):21\u201332. https:\/\/doi.org\/10.1007\/s11434-014-0695-6","journal-title":"Sci Bull"},{"key":"790_CR96","doi-asserted-by":"publisher","first-page":"103026","DOI":"10.1016\/j.redox.2024.103026","volume":"69","author":"ZJ Yang","year":"2024","unstructured":"Yang ZJ, Huang SY, Zhong KY, Huang WG, Huang ZH, He TT, Zhu HL (2024) Betaine alleviates cognitive impairment induced by homocysteine through attenuating NLRP3-mediated microglial pyroptosis in an m6A-YTHDF2-dependent manner. Redox biol 69:103026. https:\/\/doi.org\/10.1016\/j.redox.2024.103026","journal-title":"Redox biol"},{"key":"790_CR9","doi-asserted-by":"publisher","first-page":"116171","DOI":"10.1016\/j.biopha.2024.116171","volume":"173","author":"Y Yao","year":"2024","unstructured":"Yao Y, Liu P, Li Y, Wang W, Jia H, Bai Y, Yang Z (2024) Regulatory role of m6A epitranscriptomic modifications in normal development and congenital malformations during embryogenesis. Biomed Pharmacother 173:116171. https:\/\/doi.org\/10.1016\/j.biopha.2024.116171","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"790_CR39","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12929-021-00734-6","volume":"28","author":"YP Yen","year":"2021","unstructured":"Yen YP, Chen JA (2021) The m6A epitranscriptome on neural development and degeneration. J Biomed Sci 28(1):40. https:\/\/doi.org\/10.1186\/s12929-021-00734-6","journal-title":"J Biomed Sci"},{"issue":"5","key":"790_CR73","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16(5):284\u2013287. https:\/\/doi.org\/10.1089\/omi.2011.0118","journal-title":"OMICS"},{"key":"790_CR62","doi-asserted-by":"publisher","first-page":"679662","DOI":"10.3389\/fcell.2021.679662","volume":"9","author":"J Yu","year":"2021","unstructured":"Yu J, She Y, Ji SJ (2021) m6A modification in mammalian nervous system development, functions, disorders, and injuries. Front cell Dev biology 9:679662. https:\/\/doi.org\/10.3389\/fcell.2021.679662","journal-title":"Front cell Dev biology"},{"key":"790_CR98","doi-asserted-by":"publisher","first-page":"136907","DOI":"10.1016\/j.neulet.2022.136907","volume":"791","author":"Z Yu","year":"2022","unstructured":"Yu Z, Huang L, Xia Y, Cheng S, Yang C, Chen C, Zhou L (2022) Analysis of m6A modification regulators in the substantia nigra and striatum of MPTP-induced Parkinson\u2019s disease mice. Neurosci Lett 791:136907. https:\/\/doi.org\/10.1016\/j.neulet.2022.136907","journal-title":"Neurosci Lett"},{"issue":"23\u201324","key":"790_CR46","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1089\/hum.2020.106","volume":"31","author":"K Zhai","year":"2020","unstructured":"Zhai K, Liu B, Gao L (2020) Long-noncoding RNA TUG1 promotes Parkinson\u2019s disease via modulating MiR-152-3p\/PTEN pathway. Hum Gene Ther 31(23\u201324):1274\u20131287. https:\/\/doi.org\/10.1089\/hum.2020.106","journal-title":"Hum Gene Ther"},{"issue":"1","key":"790_CR44","doi-asserted-by":"publisher","first-page":"9559","DOI":"10.1038\/s41467-024-53997-6","volume":"15","author":"H Zhang","year":"2024","unstructured":"Zhang H, Luo X, Yang W, Wu Z, Zhao Z, Pei X, Hou J (2024) YTHDF2 upregulation and subcellular localization dictate CD8 T cell polyfunctionality in anti-tumor immunity. Nat Commun 15(1):9559. https:\/\/doi.org\/10.1038\/s41467-024-53997-6","journal-title":"Nat Commun"},{"key":"790_CR58","doi-asserted-by":"publisher","unstructured":"Zhang J, Ma W, Liu R, Li X, Yuan Z, Cheng J (2025) Neuromodulatory role and therapeutic potential of N6-methyladenosine RNA methylation in neurodegenerative diseases. Neural Regeneration Res 10\u20134103. https:\/\/doi.org\/10.4103\/NRR.NRR-D-24-01648","DOI":"10.4103\/NRR.NRR-D-24-01648"},{"issue":"6","key":"790_CR78","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.4103\/NRR.NRR-D-24-01648","volume":"21","author":"J Zhang","year":"2026","unstructured":"Zhang J, Ma W, Liu R, Li X, Yuan Z, Cheng J (2026) Neuromodulatory role and therapeutic potential of N6-methyladenosine RNA methylation in neurodegenerative diseases. Neural Regeneration Res 21(6):2191\u20132204. https:\/\/doi.org\/10.4103\/NRR.NRR-D-24-01648","journal-title":"Neural Regeneration Res"},{"issue":"3","key":"790_CR87","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1007\/s12035-022-02739-0","volume":"59","author":"N Zhang","year":"2022","unstructured":"Zhang N, Ding C, Zuo Y, Peng Y, Zuo L (2022) N6-methyladenosine and neurological diseases. Mol Neurobiol 59(3):1925\u20131937. https:\/\/doi.org\/10.1007\/s12035-022-02739-0","journal-title":"Mol Neurobiol"},{"issue":"3","key":"790_CR64","doi-asserted-by":"publisher","first-page":"e261","DOI":"10.1002\/mco2.261","volume":"4","author":"Q Zhong","year":"2023","unstructured":"Zhong Q, Xiao X, Qiu Y, Xu Z, Chen C, Chong B, Dai L (2023) Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms,and therapeutic implications. MedComm 4(3):e261. https:\/\/doi.org\/10.1002\/mco2.261","journal-title":"MedComm"},{"key":"790_CR74","doi-asserted-by":"publisher","first-page":"1321995","DOI":"10.3389\/fcell.2023.1321995","volume":"11","author":"J Zhou","year":"2023","unstructured":"Zhou J, Han Y, Hou R (2023) Potential role of N6-methyladenosine modification in the development of Parkinson\u2019s disease. Front Cell Dev Biology 11:1321995. https:\/\/doi.org\/10.3389\/fcell.2023.1321995","journal-title":"Front Cell Dev Biology"},{"issue":"11","key":"790_CR50","doi-asserted-by":"publisher","first-page":"5159","DOI":"10.3390\/ijms26115159","volume":"26","author":"L Zhu","year":"2025","unstructured":"Zhu L, Yi W, Zhang L, Qiu C, Sun N, He J, Feng P, Wu Q, Wang G, Wu G (2025) hnRNPH1: A Multifaceted Regulator in RNA Processing and Disease Pathogenesis. Int J Mol Sci 26(11):5159. https:\/\/doi.org\/10.3390\/ijms26115159","journal-title":"Int J Mol Sci"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-026-00790-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12640-026-00790-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-026-00790-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:47:58Z","timestamp":1777506478000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12640-026-00790-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":91,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["790"],"URL":"https:\/\/doi.org\/10.1007\/s12640-026-00790-6","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"All authors consent to the publication of this manuscript and approve the final version submitted for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}